Published in J Virol on April 16, 2008
Proteomic characterization of pseudorabies virus extracellular virions. J Virol (2011) 1.30
Herpes simplex virus requires VP11/12 to activate Src family kinase-phosphoinositide 3-kinase-Akt signaling. J Virol (2011) 0.97
Viral proteins and Src family kinases: Mechanisms of pathogenicity from a "liaison dangereuse". World J Virol (2013) 0.88
Herpes simplex virus requires VP11/12 to induce phosphorylation of the activation loop tyrosine (Y394) of the Src family kinase Lck in T lymphocytes. J Virol (2009) 0.87
Phosphorylation events during viral infections provide potential therapeutic targets. Rev Med Virol (2011) 0.86
A proteomic perspective of inbuilt viral protein regulation: pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection. Mol Cell Proteomics (2013) 0.84
Reduced degranulation of NK cells in patients with frequently recurring herpes. Clin Vaccine Immunol (2011) 0.82
Role of herpes simplex virus VP11/12 tyrosine-based motifs in binding and activation of the Src family kinase Lck and recruitment of p85, Grb2, and Shc. J Virol (2013) 0.80
Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity. J Virol (2014) 0.79
Pseudorabies virus pUL46 induces activation of ERK1/2 and regulates herpesvirus-induced nuclear envelope breakdown. J Virol (2014) 0.76
Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res (2005) 11.23
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 7.07
Herpes simplex virus turns off the TAP to evade host immunity. Nature (1995) 5.93
Genetic engineering using homologous recombination. Annu Rev Genet (2002) 5.23
Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell (1992) 5.08
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell (1994) 4.70
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A (1980) 4.35
T cells and viral persistence: lessons from diverse infections. Nat Immunol (2005) 4.12
Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene (2004) 3.63
Retracted Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature (2006) 3.47
Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion. J Virol (1980) 3.31
To kill or be killed: viral evasion of apoptosis. Nat Immunol (2002) 3.04
The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc Natl Acad Sci U S A (1997) 2.98
The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem Sci (2003) 2.85
Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect (2002) 2.43
Determination of interactions between tegument proteins of herpes simplex virus type 1. J Virol (2005) 2.31
Role of herpes simplex virus type 1 UL46 and UL47 in alpha TIF-mediated transcriptional induction: characterization of three viral deletion mutants. J Virol (1991) 2.17
Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol (1999) 2.02
Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. J Virol (1998) 2.01
Lyn tyrosine kinase: accentuating the positive and the negative. Immunity (2005) 2.01
Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression. J Virol (1993) 1.99
Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J Immunol (1996) 1.88
Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J Virol Methods (2006) 1.71
Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. Proc Natl Acad Sci U S A (1987) 1.57
Characterization and nucleotide sequence of two herpes simplex virus 1 genes whose products modulate alpha-trans-inducing factor-dependent activation of alpha genes. J Virol (1987) 1.57
Tumor and viral recognition by natural killer cells receptors. Semin Cancer Biol (2006) 1.48
Structure and expression of lck transcripts in human lymphoid cells. J Cell Biochem (1988) 1.42
Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J Virol (1998) 1.35
Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis. J Virol (2005) 1.27
Protein kinase activities associated with the virions of pseudorabies and herpes simplex virus. J Gen Virol (1985) 1.25
Synthesis, subcellular localization and VP16 interaction of the herpes simplex virus type 2 UL46 gene product. Arch Virol (2000) 1.21
Rapid directional translocations in virus replication. J Virol (2002) 1.19
Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity. J Virol (1992) 1.17
Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol (1998) 1.14
A triple entente: virus, neurons, and CD8+ T cells maintain HSV-1 latency. Immunol Res (2006) 1.11
Functional inaccessibility of quiescent herpes simplex virus genomes. Virol J (2005) 1.06
Inhibition of TCR signaling by herpes simplex virus. J Immunol (2006) 1.03
The herpes simplex virus-1 Us3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B. Cell Death Differ (2003) 1.03
Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10. J Virol (2007) 0.99
Tyrosine phosphorylation of the herpes simplex virus type 1 regulatory protein ICP22 and a cellular protein which shares antigenic determinants with ICP22. J Virol (1997) 0.99
Viral interference with MHC class I antigen presentation pathway: the battle continues. Vet Immunol Immunopathol (2005) 0.98
HIV pathogenesis: knowledge gained after two decades of research. Adv Dent Res (2006) 0.98
Immune system and hepatitis B virus infection. J Clin Virol (2005) 0.97
Hepatitis C vaccines: Inducing and challenging memory T cells. Hepatology (2006) 0.97
The Lck tyrosine kinase is expressed in brain neurons. J Neurochem (1996) 0.96
CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase. J Immunol (2003) 0.95
Herpes simplex virus L particles contain spherical membrane-enclosed inclusion vesicles. J Gen Virol (1994) 0.94
Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. J Antimicrob Chemother (2006) 0.93
Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus. Virology (2006) 0.93
Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus. J Immunol (1993) 0.91
US3 protein kinase of herpes simplex virus type 2 is required for the stability of the UL46-encoded tegument protein and its association with virus particles. J Gen Virol (2005) 0.91
Herpes simplex virus-infected cells disarm killer lymphocytes. Proc Natl Acad Sci U S A (1990) 0.89
State and role of SRC family kinases in replication of herpes simplex virus 1. J Virol (2006) 0.89
Herpes simplex virus genes Us3, Us5, and Us12 differentially regulate cytotoxic T lymphocyte-induced cytotoxicity. Viral Immunol (2006) 0.89
Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus. J Virol (1994) 0.87
PREPs: herpes simplex virus type 1-specific particles produced by infected cells when viral DNA replication is blocked. J Virol (1995) 0.87
Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. J Infect Dis (1993) 0.86
Expression of a novel form of the p56lck protooncogene in rat cerebellar granular neurons. J Neurochem (1996) 0.78
Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol (2006) 3.38
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol (2006) 2.62
The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog (2008) 2.06
Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J Virol (2002) 2.04
Viral diagnostics in the era of digital polymerase chain reaction. Diagn Microbiol Infect Dis (2012) 1.72
Clinical correlates of herpes simplex virus viremia among hospitalized adults. Clin Infect Dis (2009) 1.69
Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol (2008) 1.60
Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin Chem (2014) 1.48
Implementation of filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol (2013) 1.46
Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults. Crit Care Med (2015) 1.45
Quantitation of cytomegalovirus DNA load in dried blood spots correlates well with plasma viral load. J Clin Microbiol (2013) 1.42
Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterology (2009) 1.40
Targeted DNA mutagenesis for the cure of chronic viral infections. J Virol (2012) 1.36
Herpes simplex virus virion host shutoff protein is stimulated by translation initiation factors eIF4B and eIF4H. J Virol (2004) 1.35
Evaluation of real-time PCR versus PCR with liquid-phase hybridization for detection of enterovirus RNA in cerebrospinal fluid. J Clin Microbiol (2003) 1.35
Hematopoietic-stem-cell-based gene therapy for HIV disease. Cell Stem Cell (2012) 1.33
Tolerance of droplet-digital PCR vs real-time quantitative PCR to inhibitory substances. Clin Chem (2013) 1.33
Herpes simplex virus eliminates host mitochondrial DNA. EMBO Rep (2006) 1.32
Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI. PLoS One (2011) 1.21
Control of VP16 translation by the herpes simplex virus type 1 immediate-early protein ICP27. J Virol (2005) 1.16
Use of the MagNA pure LC automated nucleic acid extraction system followed by real-time reverse transcription-PCR for ultrasensitive quantitation of hepatitis C virus RNA. J Clin Microbiol (2004) 1.16
Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract. Elife (2013) 1.12
Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant (2005) 1.10
Targeted gene disruption to cure HIV. Curr Opin HIV AIDS (2013) 1.09
The herpes simplex virus 1 vhs protein enhances translation of viral true late mRNAs and virus production in a cell type-dependent manner. J Virol (2011) 1.08
Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant (2003) 1.08
Functional inaccessibility of quiescent herpes simplex virus genomes. Virol J (2005) 1.06
Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes. Clin Infect Dis (2013) 1.05
Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag. Retrovirology (2011) 1.05
Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach. PLoS Comput Biol (2013) 1.05
Inhibition of TCR signaling by herpes simplex virus. J Immunol (2006) 1.03
The virological synapse facilitates herpes simplex virus entry into T cells. J Virol (2009) 1.03
Comparison of FilmArray Respiratory Panel and laboratory-developed real-time reverse transcription-polymerase chain reaction assays for respiratory virus detection. Diagn Microbiol Infect Dis (2012) 1.01
Calibration curves for real-time PCR. Clin Chem (2005) 1.01
Herpes simplex virus regulatory proteins VP16 and ICP0 counteract an innate intranuclear barrier to viral gene expression. Virology (2006) 1.01
Herpes simplex virus remodels T-cell receptor signaling, resulting in p38-dependent selective synthesis of interleukin-10. J Virol (2007) 0.99
Cytomegalovirus quantitation by real-time PCR is unaffected by delayed separation of plasma from whole blood. J Clin Microbiol (2004) 0.99
Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance. J Clin Microbiol (2007) 0.98
Herpes simplex virus ICP27 is required for virus-induced stabilization of the ARE-containing IEX-1 mRNA encoded by the human IER3 gene. J Virol (2006) 0.97
Herpes simplex virus UL12.5 targets mitochondria through a mitochondrial localization sequence proximal to the N terminus. J Virol (2009) 0.97
Comparison of a multiplex real-time PCR assay with a multiplex Luminex assay for influenza virus detection. J Clin Microbiol (2013) 0.97
Evidence for translational regulation by the herpes simplex virus virion host shutoff protein. J Virol (2010) 0.97
Herpes simplex virus requires VP11/12 to activate Src family kinase-phosphoinositide 3-kinase-Akt signaling. J Virol (2011) 0.97
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial. Ann Intern Med (2015) 0.96
Herpes simplex virus VP16, but not ICP0, is required to reduce histone occupancy and enhance histone acetylation on viral genomes in U2OS osteosarcoma cells. J Virol (2009) 0.95
CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase. J Immunol (2003) 0.95
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease. Biol Blood Marrow Transplant (2005) 0.94
Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus. Virology (2006) 0.93
Comparison of the Simplexa FluA/B & RSV direct assay and laboratory-developed real-time PCR assays for detection of respiratory virus. J Clin Microbiol (2013) 0.92
RNA degradation induced by the herpes simplex virus vhs protein proceeds 5' to 3' in vitro. J Virol (2004) 0.92
Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes. J Clin Microbiol (2006) 0.91
Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy. PLoS One (2013) 0.91
Herpes simplex virus genes Us3, Us5, and Us12 differentially regulate cytotoxic T lymphocyte-induced cytotoxicity. Viral Immunol (2006) 0.89
Elimination of mitochondrial DNA is not required for herpes simplex virus 1 replication. J Virol (2013) 0.89
The XIAP IRES activates 3' cistron expression by inducing production of monocistronic mRNA in the betagal/CAT bicistronic reporter system. RNA (2009) 0.89
The antiapoptotic herpes simplex virus glycoprotein J localizes to multiple cellular organelles and induces reactive oxygen species formation. J Virol (2007) 0.88
Apoptosis prevention as a mechanism of immune evasion. Int Rev Immunol (2003) 0.88
Mitochondrial nucleases ENDOG and EXOG participate in mitochondrial DNA depletion initiated by herpes simplex virus 1 UL12.5. J Virol (2013) 0.87
Herpes simplex virus requires VP11/12 to induce phosphorylation of the activation loop tyrosine (Y394) of the Src family kinase Lck in T lymphocytes. J Virol (2009) 0.87
Cell type-specific induction and inhibition of apoptosis by Herpes Simplex virus type 2 ICP10. J Virol (2008) 0.87
Herpes simplex virus infection stabilizes cellular IEX-1 mRNA. J Virol (2005) 0.85
Herpes simplex virus-associated sepsis in a previously infected immunocompetent adult. Ann Intern Med (2003) 0.84
The potential advantages of digital PCR for clinical virology diagnostics. Expert Rev Mol Diagn (2014) 0.84
Allele-specific PCR for determination of IL28B genotype. J Clin Microbiol (2012) 0.83
Comparison of methods for extraction of viral DNA from cellular specimens. Diagn Microbiol Infect Dis (2009) 0.83
Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort. Cancer Epidemiol Biomarkers Prev (2013) 0.83
Assessment of mitochondrial toxicity by analysis of mitochondrial protein expression in mononuclear cells. Cytometry B Clin Cytom (2009) 0.82
Measuring T-cell-mediated cytotoxicity using antibody to activated caspase 3. Nat Med (2003) 0.81
Hepatitis C virus activation in HIV-infected patients initiating highly active antiretroviral therapy. AIDS Patient Care STDS (2007) 0.81
Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection. J Med Primatol (2013) 0.81
Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2. J Clin Invest (2016) 0.80
Role of herpes simplex virus VP11/12 tyrosine-based motifs in binding and activation of the Src family kinase Lck and recruitment of p85, Grb2, and Shc. J Virol (2013) 0.80
Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test. J Clin Microbiol (2012) 0.80
Cell and gene therapy strategies to eradicate HIV reservoirs. Curr Opin HIV AIDS (2016) 0.80
Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation. AIDS (2015) 0.77
TALENs targeting HBV: designer endonuclease therapies for viral infections. Mol Ther (2013) 0.76
Mass spectrometry for genotyping hepatitis C virus: a promising new approach. Clin Chem (2005) 0.75
Quantification of mitochondrial toxicity in HIV-infected individuals by quantitative PCR compared to flow cytometry. Cytometry B Clin Cytom (2012) 0.75
Attitudes and Willingness to Assume Risk of Experimental Therapy to Eradicate Genital Herpes Simplex Virus Infection. Sex Transm Dis (2016) 0.75
Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samples. J Clin Microbiol (2013) 0.75
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate. medRxiv (2020) 0.75
Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting. Sex Transm Dis (2017) 0.75
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications. Emerg Infect Dis (2022) 0.75
Cervicovaginal shedding of hepatitis C viral RNA is associated with the presence of menstrual or other blood in cervicovaginal fluids. J Clin Virol (2010) 0.75